COMMUNIQUÉS West-GlobeNewswire

Genmab Announces Financial Results for the Nine Months of 2025
06/11/2025
November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025 Highlights Announcement of Genmab’s proposed acquisition of Merus N.V. (Merus) Genmab revenue increased 21% compared to [...]
Invitation to the presentation of ALK’s first nine months (Q3) 2025 results on Thursday, 13 November 2025
06/11/2025
ALK (ALKB.DC / OMX: ALK B) will publish its results for the first nine months (Q3) of 2025 in the morning on Thursday, 13 November 2025. Later on the same day, the company will host a presentation for investors and [...]
Channel Medsystems Surpasses 5,000 Cerene® Cryotherapy Procedures, Marking Milestone in Women’s Health Innovation
06/11/2025
SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, a commercial-stage women’s health company, announced today that more than 5,000 women have now been treated with the Cerene® Cryotherapy Device, [...]
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
06/11/2025
In patients with advanced chronic kidney disease (CKD) and diabetes, treatment with rilparencel resulted in statistically significant and clinically meaningful slowing of CKD progression Bilateral kidney injection with [...]
LTC ACO Demonstrates Continued Strength, Completing All 2024 Provider Payments
06/11/2025
Top-Ranking Long-Term Care ACO Reaffirms Financial Strength and Operational Stability KENNETT SQUARE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LTC ACO , the nation’s most experienced Accountable Care Organization (ACO) [...]
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025
06/11/2025
FLORHAM PARK, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of [...]
IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025
06/11/2025
LAWRENCEVILLE, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the Company will host a [...]
Cytrellis Secures FDA Clearance for Full Body Resurfacing Using Ellacor® Micro-Coring® Technology
06/11/2025
New indication significantly expands applications for ellacor to treat sagging skin on body areas outside of the face WOBURN, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytrellis Biosystems, Inc. (“Cytrellis” or the “ [...]
Noom Unveils New Diabetes Lifestyle Program and Predictive Glucose Forecasting to Tackle America’s Diabetes Crisis
06/11/2025
Innovative tools give employers, health plans, and individuals proactive ways to prevent and manage diabetes—one of the nation’s fastest-growing and most costly chronic conditions PRINCETON, N.J., Nov. 06, 2025 (GLOBE [...]
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results
06/11/2025
Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use estimated glomerular filtration rate (eGFR) slope as an endpoint to support accelerated [...]
STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion
06/11/2025
Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansion HORSHAM, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- [...]
Solid Biosciences Awarded Innovation Passport Designation Under the New UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy
06/11/2025
- Innovation Passport award facilitates accelerated time to market and helps expedite patient access to transformative new medicines - - New Innovative Licensing and Access Pathway (ILAP) designation provides unique, [...]
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis
06/11/2025
— Phase 2 SPRING Trial Open Label Extension Showed Favorable Safety and Consistent Improvements in Key Biomarkers in PSC Patients Treated with Nebokitug for Up to 48 Weeks— —New Clinical Data Provides Insights on [...]
Dentsply Sirona Reports Third Quarter 2025 Results
06/11/2025
Dentsply Sirona Reports Third Quarter 2025 Results Net sales of $904 million decreased (5.0%) as-reported, decreased (8.0%) in constant currency including (5.5%) driven by Q3 2024 Byte impact and ERP pre-buy GAAP gross [...]
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025
06/11/2025
DURHAM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will [...]
Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025
06/11/2025
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real [...]
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
06/11/2025
PRINCETON, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets [...]
Healthcare Minus the Headache: RokketMed, A Solution to Finding the Care That Counts
06/11/2025
Turnkey San Francisco Platform Aims to Help All Employers and Workers SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- In the face of mounting healthcare compliance complexity and an urgent need for accessible [...]
Raise Craze, a partnership between the MUHC Foundation, The Beat 92.5, and Pink in the City, raised $162,160 for breast cancer care at the MUHC
06/11/2025
MONTREAL, Nov. 06, 2025 (GLOBE NEWSWIRE) -- During October’s Breast Cancer Awareness Month, the MUHC Foundation once again partnered with The Beat 92.5 and Pink in the City, raising an extraordinary $162,160 for breast [...]

Pages